meglumine and Cystadenocarcinoma, Serous

meglumine has been researched along with Cystadenocarcinoma, Serous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cherenkov, VG; Petrov, AB; Shpenkova, AA; Vasil'eva, TM	1

Trials

1 trial(s) available for meglumine and Cystadenocarcinoma, Serous

Article	Year
[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment]. Voprosy onkologii, 2012, Volume: 58, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma, Serous; Female; Humans; Meglumine; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Primary Prevention; Protective Agents; Remission Induction; Succinates	2012

Article

Year

[Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment].

Voprosy onkologii, 2012, Volume: 58, Issue:1

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma, Serous; Female; Humans; Meglumine; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Primary Prevention; Protective Agents; Remission Induction; Succinates

2012